Bio Pharma Dive
NOVEMBER 22, 2024
The approval of Attruby for transthyretin amyloidosis with cardiomyopathy begins a battle for control of a lucrative market that investors have been skeptical BridgeBio can win.
Pharmaceutical Technology
NOVEMBER 22, 2024
Several pharmaceutical companies are advancing dry powder inhalers (DPIs) for respiratory conditions in an effort to cut down on greenhouse emissions and create a solution that is more eco-friendly than traditional pressurised metered-dose inhalers (pMDIs).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
NOVEMBER 22, 2024
Evotec appears to have rebuffed Halozyme’s $2.1 billion acquisition attempt. Elsewhere, Argenx has another blockbuster target in sight and an FDA veteran plans retirement.
Pharmaceutical Technology
NOVEMBER 22, 2024
Novartis has announced the acquisition of Kate Therapeutics to enhance its portfolio of gene therapies for inherited neuromuscular diseases.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Bio Pharma Dive
NOVEMBER 22, 2024
A prolific medical research and author, Martin Makary criticized the FDA and CDC for their decision-making during the pandemic, although he describes himself as pro-vaccine.
Pharmaceutical Technology
NOVEMBER 22, 2024
The biotech uses its AI platform to discover the therapeutic potential of plant-based molecules, advancing ten candidates with the funds.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
NOVEMBER 22, 2024
Health Canada has issued a Notice of Compliance (NOC) for Johnson & Johnson’s (J&J) CARVYKTI for multiple myeloma treatment.
Bio Pharma Dive
NOVEMBER 22, 2024
Despite plans to shutter 1,200 stores, the company’s chief clinical trials officer said the pharmacy giant remains committed to aiding drug research.
Pharmaceutical Technology
NOVEMBER 22, 2024
Johnson & Johnson Innovation Medicine has submitted a request to the FDA to approve Tremfya as a treatment for ulcerative colitis.
Rethinking Clinical Trials
NOVEMBER 22, 2024
                         Speaker M. Kit Delgado, MD, MS Associate Professor of Emergency Medicine and Epidemiology Faculty Director, Penn Medicine Nudge Unit Slides Keywords Distracted Driving; Auto Insurance; Smartphones Key Points Distracted driving leads to over 800,000 crashes, over 400,000 injuries, and over 3,000 deaths per year.
Pharmaceutical Technology
NOVEMBER 22, 2024
The UK’s proposed regulations would provide the legal framework for POC manufacturing of cell therapies, including quality assurance.
Medical Xpress
NOVEMBER 22, 2024
A University of Queensland-led team analyzed data for 204 countries and territories, to assess global access to adequate mental health care. The study involved researchers from the University of Washington, the World Health Organization and Harvard University and was published in The Lancet Psychiatry.
Pharmaceutical Technology
NOVEMBER 22, 2024
Amneal Pharmaceuticals has submitted another NDA for its DHE prefilled syringe autoinjector to treat tough-to-treat headaches.
Medical Xpress
NOVEMBER 22, 2024
Researchers at Penn State are using machine learning and existing electrocardiogram (ECG) data to help doctors make more accurate predictions. A team of artificial intelligence engineers, in collaboration with a team of physicians from Penn State Heart and Vascular Institute, is working to develop novel algorithms for point-of-care, in-house use and for technology licensing.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Technology
NOVEMBER 22, 2024
Novo Nordisk and Ypsomed’s 2023 deal is rumoured to include an autoinjector supply for potential Wegovy successor CagriSema.
Medical Xpress
NOVEMBER 22, 2024
An international research team, led by the University of Wollongong (UOW), has found wearable organic X-ray sensors could offer safer radiotherapy protocols for cancer patients.
Pharmaceutical Technology
NOVEMBER 22, 2024
Zai Lab and Pfizer have entered a strategic collaboration for the commercialisation of XACDURO in mainland China.
Medical Xpress
NOVEMBER 22, 2024
Howard Hughes Medical Institute-led research has uncovered three neural circuit mechanisms that enable female fruit flies to modify their visual processing during aggressive interactions.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharmaceutical Technology
NOVEMBER 22, 2024
TCR immunotherapy is emerging as a promising, targeted approach for treating solid tumours and other indications.
Medical Xpress
NOVEMBER 22, 2024
Adolescents who snore frequently were more likely to exhibit behavior problems such as inattention, rule-breaking, and aggression, but they do not have any decline in their cognitive abilities, according to a new study conducted by researchers at the University of Maryland School of Medicine (UMSOM).
Fierce Pharma
NOVEMBER 22, 2024
As other Big Pharmas face local headwinds, Pfizer doubles down on China commitment with Zai Lab antimicrobial marketing pact fkansteiner Fri, 11/22/2024 - 09:04
Medical Xpress
NOVEMBER 22, 2024
Just as crop-devouring insects evolve to resist pesticides, cancer cells can increase their lethality by developing resistance to treatment. In fact, most deaths from cancer are caused by the evolution of therapeutic resistance.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
NOVEMBER 22, 2024
Jazz Pharma has claimed FDA approval for its HER2-directed bispecific antibody Ziihera as a treatment for biliary tract cancer
Medical Xpress
NOVEMBER 22, 2024
Children's books are full of animal characters whose antics capture the hearts and inspire the imaginations of their young readers.
pharmaphorum
NOVEMBER 22, 2024
The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Medical Xpress
NOVEMBER 22, 2024
LMU researchers have discovered how the interplay between a key protein and an endolysosomal ion channel promotes tumor development in skin cancer.
Advertiser: FourKites
A research study conducted by The Journal of Commerce and FourKites surveyed hundreds of international shippers, exploring how their usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19. For international shippers, ocean freight visibility has evolved from optional to essential and satisfaction with visibility varies greatly depending on how it is obtained and delivered.
XTalks
NOVEMBER 22, 2024
NewAmsterdam Pharma announced promising results from its Phase III TANDEM clinical trial, evaluating a fixed-dose combination of obicetrapib and ezetimibe. This therapy targets patients with high cardiovascular risk due to atherosclerotic cardiovascular disease (ASCVD), ASCVD risk factors or heterozygous familial hypercholesterolemia (HeFH). In the news release , John Kastelein, chief scientific officer of NewAmsterdam Pharma, said millions of people struggle to meet low-density lipoprotein chol
Medical Xpress
NOVEMBER 22, 2024
Head and neck cancers are the seventh most common type of cancer worldwide, according to the 2020 World Cancer Report. Smokers and drinkers, as well as those with HPV infections, are disproportionately affected.
Fierce Pharma
NOVEMBER 22, 2024
While Johnson & Johnson hopes to soon resolve more than 60,000 talc lawsuits with an $8 billion bankruptcy settlement in the United States, its baby power problems are only just beginning in th | While Johnson & Johnson hopes to soon resolve more than 60,000 talc lawsuits with an $8 billion bankruptcy settlement in the United States, its baby power problems are only just beginning in the U.K.
Medical Xpress
NOVEMBER 22, 2024
A 57-year-old woman with COPD has received the world's first fully robotic double lung transplant.
Expert insights. Personalized for you.
208 
Let's personalize your content